{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:38:18Z","timestamp":1776494298307,"version":"3.51.2"},"reference-count":34,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erythrodermic psoriasis (EP) is a rare but severe condition. Because of its low prevalence, there are no standardized treatment recommendations for EP. Specific EP guidelines are outdated, prioritizing conventional disease\u2010modifying antirheumatic drugs (cDMARDs) and tumor necrosis factor\u2010alpha (TNF\u2010\u03b1) inhibitors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multicenter retrospective chart analysis in five academic centers in Bavaria, Germany (Augsburg, Erlangen, LMU Munich, TU Munich, Regensburg). Patients diagnosed with EP between 2019 and 2024 who received systemic treatment were included in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 29 patients were included. cDMARDs were initiated in 8 patients (27.6%). Biologics were used in 21 patients (72.4%). Psoriasis Area and Severity Index (PASI) decreased from 31.9 to 10.8 across all therapies (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). PASI 75 was achieved with methotrexate (1), cyclosporine (1), fumarates (1), infliximab (1), ustekinumab (2), ixekizumab (1), secukinumab (2), risankizumab (4), and guselkumab (1). PASI 100 was achieved with infliximab (1), ustekinumab (1), and risankizumab (2). Adverse events occurred most frequently in the cDMARDs group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a wide variety of treatment approaches. Standardized guidelines are needed. Biologic therapies, especially interleukin (IL)17 and IL23\u2010inhibitors, showed favorable outcomes in this cohort and warrant prospective evaluation.<\/jats:p>\n                    <jats:p>\n                      <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                        <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/ijd70422-gra-0001-m.png\">\n                          <jats:alt-text>image<\/jats:alt-text>\n                        <\/jats:graphic>\n                      <\/jats:boxed-text>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/ijd.70422","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:39:27Z","timestamp":1776490767000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Treatment and Outcome in Erythrodermic Psoriasis: A Retrospective Multicenter Study"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6164-5227","authenticated-orcid":false,"given":"Julian","family":"K\u00f6gel","sequence":"first","affiliation":[{"name":"Department of Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-7619","authenticated-orcid":false,"given":"Sandra","family":"Schuh","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital Augsburg  Augsburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6099-7418","authenticated-orcid":false,"given":"Julia","family":"Welzel","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology University Hospital Augsburg  Augsburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9396-3938","authenticated-orcid":false,"given":"Michael","family":"Sticherling","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Erlangen  Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-0821","authenticated-orcid":false,"given":"Lukas","family":"Sollfrank","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Erlangen  Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-8931","authenticated-orcid":false,"given":"Carola","family":"Berking","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Erlangen  Erlangen Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teodora","family":"Pumnea","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian\u2010University  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Glatzel","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian\u2010University  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"French","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian\u2010University  Munich Germany"},{"name":"Dr. Phillip Frost, Department of Dermatology and Cutaneous Surgery University of Miami, Miller School of Medicine  Miami Florida USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1992-2836","authenticated-orcid":false,"given":"Felix","family":"Lauffer","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Ludwig\u2010Maximilian\u2010University  Munich Germany"},{"name":"Department of Dermatology and Allergology Technical University Munich  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin Valentin","family":"Vitus","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Technical University Munich  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilo","family":"Biedermann","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Allergology Technical University Munich  Munich Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5108-1696","authenticated-orcid":false,"given":"Susanne","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Spindler","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-0486","authenticated-orcid":false,"given":"Dennis","family":"Niebel","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital Regensburg  Regensburg Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2230.2001.00832.x","article-title":"Psoriasis\u2014Epidemiology and Clinical Spectrum","volume":"26","author":"Christophers E.","year":"2001","journal-title":"Clinical and Experimental Dermatology"},{"key":"e_1_2_13_3_1","first-page":"563","article-title":"Clinical Analysis of 84 Cases of Erythrodermic Psoriasis and 121 Cases of Other Types of Erythroderma From 2010\u20132015","volume":"37","author":"Zhang P.","year":"2017","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"key":"e_1_2_13_4_1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0190-9622(89)70287-5","article-title":"Erythrodermic Psoriasis","volume":"21","author":"Boyd A. S.","year":"1989","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_13_5_1","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1932.02740770032007","article-title":"Erythroderma Psoriaticum","volume":"99","author":"Goeckerman W. H.","year":"1932","journal-title":"JAMA"},{"key":"e_1_2_13_6_1","first-page":"596","article-title":"Analysis of Th1\/Th2 Response Pattern for Erythrodermic Psoriasis","volume":"34","author":"Zhang P.","year":"2014","journal-title":"Journal of Huazhong University of Science and Technology. Medical Sciences"},{"key":"e_1_2_13_7_1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2230.2004.01717.x","article-title":"Serum Immunoglobulins in Psoriatic Erythroderma","volume":"30","author":"Li L.\u2010F.","year":"2005","journal-title":"Clinical and Experimental Dermatology"},{"key":"e_1_2_13_8_1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cyto.2009.09.014","article-title":"Wide\u2010Spectrum Profile of Inflammatory Mediators in the Plasma and Scales of Patients With Psoriatic Disease","volume":"49","author":"Deeva I.","year":"2010","journal-title":"Cytokine"},{"key":"e_1_2_13_9_1","first-page":"93","article-title":"Erythrodermic Psoriasis: Pathophysiology and Current Treatment Perspectives","volume":"6","author":"Singh R. K.","year":"2016","journal-title":"Psoriasis (Auckl)"},{"key":"e_1_2_13_10_1","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000078690","article-title":"Erythroderma: A Clinical Study of 127 Cases and Review of the Literature","volume":"2","author":"El Euch D.","year":"2003","journal-title":"Exogenous Dermatology"},{"key":"e_1_2_13_11_1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-5945-5-5","article-title":"Erythroderma: A Clinical Study of 97 Cases","volume":"5","author":"Akhyani M.","year":"2005","journal-title":"BMC Dermatology"},{"key":"e_1_2_13_12_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.adengl.2018.05.033","article-title":"A Practical Approach to the Diagnosis and Treatment of Adult Erythroderma","volume":"109","author":"Cuellar\u2010Barboza A.","year":"2018","journal-title":"Actas Dermo\u2010Sifiliogr\u00e1ficas (English Edition)"},{"key":"e_1_2_13_13_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0190-9622(96)90078-X","article-title":"Infectious Complications of Erythrodermic Psoriasis","volume":"34","author":"Green M. S.","year":"1996","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_13_14_1","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1169474","article-title":"Heart Failure in Erythrodermic Psoriasis: A Retrospective Study of 225 Patients","volume":"10","author":"Wu C.","year":"2023","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"e_1_2_13_15_1","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaad.2009.05.048","article-title":"Treatment of Erythrodermic Psoriasis: From the Medical Board of the National Psoriasis Foundation","volume":"62","author":"Rosenbach M.","year":"2010","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_13_16_1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1080\/14712598.2022.2128669","article-title":"Biological Treatment for Erythrodermic Psoriasis","volume":"22","author":"Dogra S.","year":"2022","journal-title":"Expert Opinion on Biological Therapy"},{"key":"e_1_2_13_17_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/09546634.2019.1689228","article-title":"A Systematic Review of Treatment Strategies for Erythrodermic Psoriasis","volume":"32","author":"Reynolds K. A.","year":"2021","journal-title":"Journal of Dermatological Treatment"},{"key":"e_1_2_13_18_1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/ddg.14508_g","article-title":"Deutsche S3\u2010Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm \u2010 Teil 1: Therapieziele und Therapieempfehlungen","volume":"19","author":"Nast A.","year":"2021","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"e_1_2_13_19_1","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/ddg.14507_g","article-title":"Deutsche S3\u2010Leitlinie zur Therapie der Psoriasis vulgaris, adaptiert von EuroGuiDerm \u2010 Teil 2: Therapiemonitoring, besondere klinische Situationen und Komorbidit\u00e4t","volume":"19","author":"Nast A.","year":"2021","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"e_1_2_13_20_1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm Guideline on the Systemic Treatment of Psoriasis Vulgaris \u2010 Part 1: Treatment and Monitoring Recommendations","volume":"34","author":"Nast A.","year":"2020","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_13_21_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/jdv.16926","article-title":"EuroGuiDerm Guideline on the Systemic Treatment of Psoriasis Vulgaris \u2010 Part 2: Specific Clinical and Comorbid Situations","volume":"35","author":"Nast A.","year":"2021","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_13_22_1","first-page":"841","article-title":"Erythrodermie psoriasique: profil \u00e9pid\u00e9mio\u2010clinique et th\u00e9rapeutique \u00e0 propos de 60 cas","volume":"89","author":"Hawilo A.","year":"2011","journal-title":"La Tunisie M\u00e9dicale"},{"issue":"1","key":"e_1_2_13_23_1","first-page":"30","article-title":"Studio Italiano Multicentrico nella Psoriasi (SIMPSO)","volume":"187","author":"Management of Erythrodermic Psoriasis With Low\u2010Dose Cyclosporin","year":"1993","journal-title":"Dermatology"},{"key":"e_1_2_13_24_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2230.1992.tb02161.x","article-title":"The Efficacy of Methotrexate in Psoriasis\u2013A Review of 40 Cases","volume":"17","author":"Collins P.","year":"1992","journal-title":"Clinical and Experimental Dermatology"},{"key":"e_1_2_13_25_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1525-1470.1994.tb00602.x","article-title":"Methotrexate in Childhood Psoriasis","volume":"11","author":"Kumar B.","year":"1994","journal-title":"Pediatric Dermatology"},{"key":"e_1_2_13_26_1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2133.2012.10940.x","article-title":"Efficacy and Safety of Biologics in Erythrodermic Psoriasis: A Multicentre, Retrospective Study","volume":"167","author":"Viguier M.","year":"2012","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_13_27_1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jdermsci.2015.01.005","article-title":"Erythrodermic Psoriasis Treated With Ustekinumab: An Italian Multicenter Retrospective Analysis","volume":"78","author":"Pescitelli L.","year":"2015","journal-title":"Journal of Dermatological Science"},{"key":"e_1_2_13_28_1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/1346-8138.13622","article-title":"Efficacy and Safety of Ixekizumab Treatment for Japanese Patients With Moderate to Severe Plaque Psoriasis, Erythrodermic Psoriasis and Generalized Pustular Psoriasis: Results From a 52\u2010Week, Open\u2010Label, Phase 3 Study (UNCOVER\u2010J)","volume":"44","author":"Saeki H.","year":"2017","journal-title":"Journal of Dermatology"},{"key":"e_1_2_13_29_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/jcm8060770","article-title":"Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study","volume":"8","author":"Damiani G.","year":"2019","journal-title":"Journal of Clinical Medicine"},{"key":"e_1_2_13_30_1","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1111\/jdv.18069","article-title":"Real\u2010Life Comparison Between Secukinumab and Ixekizumab in the Treatment of Pustular and Erythrodermic Psoriasis","volume":"36","author":"Avallone G.","year":"2022","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_13_31_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/1346-8138.16667","article-title":"Efficacy and Safety of Risankizumab in Japanese Patients With Generalized Pustular Psoriasis or Erythrodermic Psoriasis: Primary Analysis and 180\u2010Week Follow\u2010Up Results From the Phase 3, Multicenter IMMspire Study","volume":"50","author":"Yamanaka K.","year":"2023","journal-title":"Journal of Dermatology"},{"key":"e_1_2_13_32_1","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjd.12214","article-title":"Long\u2010Term Safety of Ustekinumab in Patients With Moderate\u2010To\u2010Severe Psoriasis: Final Results From 5\u2009Years of Follow\u2010Up","volume":"168","author":"Papp K. A.","year":"2013","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_13_33_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15030","article-title":"Tildrakizumab: A New Therapeutic Option for Erythrodermic Psoriasis?","volume":"34","author":"Megna M.","year":"2021","journal-title":"Dermatologic Therapy"},{"key":"e_1_2_13_34_1","doi-asserted-by":"crossref","DOI":"10.4081\/dr.2022.9448","article-title":"Erythrodermic Psoriasis Improved by Tildrakizumab","volume":"14","author":"Trevisan G.","year":"2022","journal-title":"Dermatology Reports"},{"key":"e_1_2_13_35_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-54559-6","article-title":"Immune Modules to Guide Diagnosis and Personalized Treatment of Inflammatory Skin Diseases","volume":"15","author":"Seremet T.","year":"2024","journal-title":"Nature Communications"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.70422","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijd.70422","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.70422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:39:32Z","timestamp":1776490772000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.70422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":34,"alternative-id":["10.1111\/ijd.70422"],"URL":"https:\/\/doi.org\/10.1111\/ijd.70422","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"2026-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ijd.70422"}}